Wisdom Teeth Removal Adelaide | Oral Health Series | min 7 read

Polycystic Ovary Syndrome (PCOS) is one of Australia's most common yet most misunderstood women's health conditions. Affecting one in eight Australian women of reproductive age, PCOS is far more than a reproductive disorder it is a complex, systemic, hormonal and metabolic condition with wide-reaching consequences for cardiovascular health, mental wellbeing, and increasingly, oral health (Teede et al., 2024).

For women living with PCOS in Adelaide, the connection between their hormonal health and their teeth including wisdom teeth may not be something their GP or gynaecologist has ever raised. Yet a growing body of peer-reviewed evidence shows that the same chronic inflammation and hormonal disruption that define PCOS create a significantly heightened susceptibility to gum disease, altered oral microbiome, and complications from impacted wisdom teeth. This blog explores what the science says, why it matters for your dental care, and what you can do about it.

What Is PCOS? A Brief Overview for Dental Patients

PCOS is a genetic and lifestyle-related chronic endocrine condition characterised primarily by hyperandrogenism (elevated androgens), insulin resistance, and ovulatory dysfunction. It affects between 10 and 13 percent of women globally, making it the most common endocrinopathy among women of reproductive age (Teede et al., 2023). In Australia alone, the associated healthcare costs exceed $800 million annually, yet PCOS remains chronically underdiagnosed, undertreated, and poorly understood outside specialist reproductive medicine (Monash University, 2023).

The 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS led by Australia's National Health and Medical Research Council represents the most comprehensive clinical guidance to date. It recognises that PCOS extends far beyond fertility and menstrual irregularity, with significant implications for metabolic health (including increased risk of type 2 diabetes and cardiovascular disease), psychological wellbeing, and dermatological manifestations such as acne, hirsutism, and hair loss (Teede et al., 2023). What the guideline does not yet explicitly address but what emerging research increasingly supports is the important relationship between PCOS and oral health.

The PCOS–Oral Health Connection: What Research Shows

The link between PCOS and oral health is bidirectional and mechanistically complex. At its core, the relationship is driven by three overlapping biological pathways: chronic systemic inflammation, hyperandrogenism, and insulin resistance all hallmarks of PCOS that also independently increase susceptibility to periodontal disease.

A 2023 Mendelian randomisation study published in Frontiers in Endocrinology one of the most methodologically rigorous study designs for establishing causal relationships found a statistically significant association between PCOS and multiple oral inflammatory conditions, including painful gums, mouth ulcers, and loose teeth (Min et al., 2024). The authors noted that elevated luteinising hormone (LH) in PCOS was particularly associated with oral inflammatory disease risk and recommended early preventive dental intervention for women with PCOS, especially those with elevated LH levels.

A cross-sectional study comparing periodontal status in women with PCOS versus healthy controls found that despite similar oral hygiene scores between the two groups, women with PCOS had significantly higher gingival inflammation scores, clinical periodontal indices, and loss of attachment (a marker of gum disease severity) than their healthy counterparts (p<0.001) (Dahiya et al., 2023). The researchers concluded that a common pathophysiological pathway — namely chronic systemic inflammation and insulin resistance — likely underlies both PCOS and periodontal disease.

'Women with PCOS had significantly higher periodontal inflammation markers than healthy women despite similar oral hygiene — suggesting that PCOS itself, not hygiene habits, drives the heightened risk.' (Dahiya et al., 2023)

How PCOS Hormones Affect the Mouth: The Role of Androgens and Inflammation

Understanding why PCOS affects oral health requires understanding how hormones interact with gum tissue. Human gingiva, the soft tissue surrounding the teeth, contains receptors for oestrogen, progesterone, and testosterone. Female sex steroid hormones actively modulate the gingival inflammatory response, wound healing, and the composition of the oral microbiome. When these hormones are dysregulated, as they are in PCOS, the consequences extend directly to the mouth.

A study published in BMC Oral Health examined salivary inflammatory cytokines and gingival health in adolescent females with PCOS. Despite similar periodontal parameters between groups, women with PCOS had significantly elevated levels of pro-inflammatory cytokines in saliva including tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) compared to healthy controls (Wendland et al., 2021). Salivary testosterone was positively correlated with TNF-α, and free androgen index was correlated with TNF-α levels. This confirms that the androgen excess characteristic of PCOS drives a measurable pro-inflammatory state in the oral environment, independent of visible gum disease.

A separate study examining salivary pathogens in 125 women found that those with PCOS had significantly higher levels of key periodontal bacteria including Porphyromonas gingivalis, Fusobacterium nucleatum, and Tannerella forsythia compared to systemically healthy women (Akcalı et al., 2014). These pathogens are not just local actors: P. gingivalis, in particular, has been linked to systemic inflammation, insulin resistance, and cardiovascular disease risk creating a vicious cycle between oral infection and PCOS metabolic complications.

Wisdom Teeth, PCOS, and Pericoronitis: A Higher-Risk Scenario

For women with PCOS, impacted wisdom teeth represent a specific and underappreciated risk. Here is why: wisdom teeth that are partially erupted create an anatomical pocket beneath the gum tissue known as the operculum where bacteria accumulate and trigger pericoronitis, an acute infection of the surrounding gum. In healthy individuals, pericoronitis is typically a self-limiting or easily managed condition. In women with PCOS, the hormonal, metabolic, and immunological environment significantly worsens the picture.

Clinical literature from the National Institutes of Health notes that systemic conditions that compromise immune function explicitly including diabetes and insulin resistance increase the risk of developing pericoronitis and worsen its clinical course (Nguyen et al., 2022). Given that insulin resistance affects the majority of women with PCOS (irrespective of weight), PCOS represents precisely the kind of systemic immune compromise that makes impacted wisdom teeth more dangerous, not less.

Pericoronitis generates a localised but potent inflammatory cascade. In a woman whose systemic inflammatory markers (CRP, IL-6, TNF-α) are already elevated due to PCOS, an infected wisdom tooth adds a further inflammatory load to an already burdened system. This matters because chronic systemic inflammation in PCOS is already a key driver of insulin resistance and cardiovascular risk and any additional source of infection amplifies that burden.

Furthermore, menstruation a trigger for pericoronitis flare-ups is itself erratic in many women with PCOS. The hormonal fluctuations associated with irregular cycles, anovulation, and PCOS-related endocrine disruption create a less predictable and less stable oral environment, making partially erupted wisdom teeth a persistent vulnerability.

The Shared Inflammatory Pathway: Why Treating Gum Disease May Help PCOS

Perhaps the most clinically significant and hopeful dimension of the PCOS–oral health relationship is its bidirectionality. Research published in Frontiers in Endocrinology found that periodontal disease may increase the risk of PCOS through gut microbiota disruption and the induction of low-grade systemic inflammation and oxidative stress (Dou et al., 2023). This suggests that the relationship is not simply 'PCOS causes gum disease' but gum disease may actively worsen PCOS through the same inflammatory mechanisms.

A clinical trial is currently investigating whether non-surgical periodontal therapy combined with myo-inositol (an insulin-sensitising supplement widely used in PCOS management) can improve both periodontal and metabolic outcomes in women with PCOS and chronic periodontitis. The hypothesis is grounded in established evidence that reducing oral inflammation reduces systemic CRP and IL-6 the same markers that drive insulin resistance in PCOS.

This has a direct practical implication: for women with PCOS, treating oral disease including removing chronically infected or impacted wisdom teeth is not merely about dental hygiene. It is a metabolic health intervention. Resolving a persistent source of oral infection may reduce systemic inflammatory burden, support insulin sensitivity, and complement other PCOS management strategies including diet, exercise, and metformin therapy.

PCOS, Oral Health Awareness, and the Gap in Care

Despite the compelling scientific evidence, awareness of the oral health consequences of PCOS among both patients and healthcare providers remains low. A qualitative study published in the International Journal of Community Medicine and Public Health explored oral health awareness among women with PCOS and identified a consistent pattern: women with PCOS had largely not been informed of the connection between their condition and their dental health, and many had not discussed oral symptoms with their doctor or dentist (Nivedha et al., 2023).

The 2023 International PCOS Guideline, led by Monash University and funded by Australia's NHMRC, explicitly acknowledges that PCOS is a neglected women's health condition with limited education in undergraduate health curricula and calls for better integrated, multidisciplinary care (Teede et al., 2023). The guideline's vision of lifelong, holistic health management for women with PCOS should naturally include dental and oral health as part of the care plan.

For Adelaide women with PCOS, this means proactively discussing your PCOS diagnosis with your dentist particularly when it comes to wisdom teeth assessment. Your dentist needs to understand your systemic inflammatory and hormonal status to provide the most appropriate, individualised advice about whether and when wisdom teeth removal is recommended.

What Women with PCOS Should Know About Wisdom Teeth Removal

If you have PCOS and have been told you have impacted or partially erupted wisdom teeth, the following considerations are particularly relevant:

•        Higher infection risk: Your elevated baseline inflammatory markers and insulin resistance make pericoronitis more likely and potentially more severe if impacted wisdom teeth are left untreated.

•        Compounding systemic inflammation: A chronically infected wisdom tooth adds inflammatory burden including elevated CRP, IL-6, and TNF-α that may worsen insulin resistance and PCOS metabolic features.

•        Healing considerations: Women with PCOS who also have insulin resistance may experience slightly different wound healing responses. Your oral surgeon should be informed of your PCOS diagnosis and any medications you are taking (including metformin, combined oral contraceptive pill, or inositol supplements).

•        Hormonal fluctuations and pericoronitis: The hormonal variability associated with PCOS particularly irregular cycles may make wisdom tooth infections harder to predict and more likely to recur. Definitive extraction is often the most appropriate long-term management.

•        Early assessment is valuable: Wisdom teeth are easiest to remove in the late teens and early twenties, before roots are fully formed. If you were diagnosed with PCOS in adolescence or early adulthood, an early dental OPG assessment is strongly advisable. 

Practical Oral Health Recommendations for Women with PCOS

Given the current evidence, the following oral health practices are particularly important for women with PCOS:

•        Inform your dentist of your PCOS diagnosis at your first appointment and at any treatment planning consultation. This is clinical information, not background noise it changes your risk profile.

•        Attend regular dental check-ups (at least every six months) with periodontal assessment. PCOS is an independent risk factor for gum disease; proactive monitoring is essential.

•        Request an OPG (panoramic dental X-ray) to assess wisdom tooth position if you have not had one. This is the gold standard for evaluating impaction status and planning management.

•        Discuss any symptoms of pericoronitis pain or swelling at the back of the mouth, difficulty opening fully, bad taste or odour with your dentist promptly. In women with PCOS, these symptoms warrant early assessment rather than a wait-and-see approach.

•        Prioritise anti-inflammatory dietary choices: high-fibre, low-glycaemic index foods that support PCOS metabolic management also reduce periodontal inflammation. The whole-food dietary recommendations for PCOS management align well with the dietary advice for gum disease prevention.

•        If you use metformin or the combined oral contraceptive pill for PCOS management, inform your oral surgeon before any dental procedure, as these medications have minor but relevant implications for surgical planning and recovery.

Summary

•        PCOS affects one in eight Australian women and is driven by chronic systemic inflammation, hyperandrogenism, and insulin resistance all of which directly affect oral health.

•        Women with PCOS have significantly higher rates of periodontal disease and elevated oral inflammatory cytokines compared to healthy women, even with similar oral hygiene (Pavankumar et al., 2023)

•        PCOS alters the oral microbiome, increasing colonisation by periodontal pathogens including Porphyromonas gingivalis and Fusobacterium nucleatum (Akcalı et al., 2014) .

•        Impacted wisdom teeth in women with PCOS carry a heightened risk due to immune compromise from insulin resistance and the pro-inflammatory systemic environment.

•        The relationship between PCOS and periodontal disease is bidirectional: oral infection may worsen PCOS metabolic features by amplifying systemic inflammation and insulin resistance.

•        Treating oral disease including removing problematic wisdom teeth may reduce systemic inflammatory burden and support PCOS metabolic management.

•        Women with PCOS should proactively disclose their diagnosis to their dentist and prioritise regular periodontal assessment and early wisdom teeth evaluation.

Call 8185 0024 or BOOK ONLINE

References

Akcalı, A., Bostanci, N., Özçaka, Ö., Öztürk-Ceyhan, B., Gümüş, P., Buduneli, N., & Belibasakis, G. N. (2014). Association between polycystic ovary syndrome, oral microbiota and systemic antibody responses. PLoS ONE, 9(9), e108074. https://doi.org/10.1371/journal.pone.0108074 

Pavankumar, S., Yellarthi, P. K., Jn, S., Boyapati, R., Damera, T. K., & Kumar, N. V. G. (2023). Evaluation of periodontal status in women with polycystic ovary syndrome versus healthy women: A cross-sectional study. Yeungnam University Journal of Medicine, 40(4), 328–335. https://doi.org/10.12701/jyms.2023.00143 

Dou, Y., Xin, J., Zhou, P., Tang, J., Xie, H., Fan, W., Zhang, Z., & Wu, D. (2023). Bidirectional association between polycystic ovary syndrome and periodontal diseases. Frontiers in Endocrinology, 14, Article 1008675. https://doi.org/10.3389/fendo.2023.1008675 

Wendland, N., Opydo-Szymaczek, J., Formanowicz, D., Blacha, A., Jarząbek-Bielecka, G., & Mizgier, M. (2021). Association between metabolic and hormonal profile, proinflammatory cytokines in saliva and gingival health in adolescent females with polycystic ovary syndrome. BMC Oral Health, 21(1), 150. https://doi.org/10.1186/s12903-021-01553-9 

Marcickiewicz, J., Jamka, M., & Walkowiak, J. (2025). A potential link between oral microbiota and female reproductive health. Nutrients, 17(6), Article 1075. https://doi.org/10.3390/nu17061075 

Min, Q., Chen, Y., Geng, H., Gao, Q., Zhang, X., & Xu, M. (2024). Causal relationship between PCOS and related sex hormones with oral inflammatory diseases: A bidirectional Mendelian randomization study. Frontiers in Endocrinology, 14, 1282056. https://doi.org/10.3389/fendo.2023.1282056

Monash University. (2023). Australia leads the world with a new international guideline to improve the health of women with polycystic ovary syndrome. https://www.monash.edu/news/articles/australia-leads-the-world-with-a-new-international-guideline-to-improve-the-health-of-women-with-polycystic-ovary-syndrome

Nivedha, K., Aparna, S., & Madankumar, P. D. (2023). Awareness regarding oral health among women with polycystic ovary syndrome: A qualitative study. International Journal of Community Medicine and Public Health, 10(6), 2207–2211. https://doi.org/10.18203/2394-6040.ijcmph20231299 

Nguyen, D. H., Martin, J. T., & Thomas, J. (2022). Pericoronitis. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK576411/

Joseph, R. A., Ajitkumar, S., Balaji, S. K., & Santhanakrishnan, M. (2023). Evaluation of microbial profile in patients with polycystic ovary syndrome and periodontal disease: A case-control study. International Journal of Fertility and Sterility, 17(4), 248–253. https://doi.org/10.22074/ijfs.2023.550187.1272

Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., ... & Boivin, J. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism, 108(10), 2447–2469. https://doi.org/10.1210/clinem/dgad463

Teede, H. J., Gibson-Helm, M., Norman, R. J., & Boyle, J. (2024). Summary of the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome: An Australian perspective. Medical Journal of Australia, 221(7). https://doi.org/10.5694/mja2.52432